Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence
Katerina Baou1, Vasiliki Katsi2, Thomas Makris3
1First Department of Pulmonary Medicine, Sismanoglio Hospital, Sismanogliou 1, Marousi, Greece.
Abstract:
Approximately half a century has passed since the discovery of beta-blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias; nowadays, beta-blockers' usage and effectiveness are extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta- blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After thorough research of the literature, this review summarizes the evidence proving that beta-blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients.
More Related Videos
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
Antihypertensive Drugs: Types of β-Blockers
COPD: Management Using Bronchodilators and Corticosteroids
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Heart Failure Drugs: β-Blockers
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation